Search research articles
Contact Us
Filters
Showing results (271-280 of 841) with videos related to
Page
of 85
Sort By:
Anxiety
|
January 1, 1996
What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?
A W Buchanan, K S Meng, I M Marks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1981
Pitfalls in technetium-99m HIDA biliary imaging: duodenal diverticulum simulating the gallbladder
J F Brown, J W Buchanan, H N Wagner
British Journal of Clinical Pharmacology
|
October 1, 1988
Comparison of the natural history of untreated acute gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs
M H Arnold, S J Preston, W W Buchanan
International Clinical Psychopharmacology
|
August 5, 1998
The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
C A Tamminga, R W Buchanan, J M Gold
Schizophrenia Bulletin Open
|
August 15, 2024
Time to Stop Using the Term Relapse in Schizophrenia Clinical Trials
William T Carpenter, Robert W Buchanan, Stephen R Marder
Annals of the Rheumatic Diseases
|
January 1, 1974
Proceedings: Technique for assessing the potential effectiveness of antirheumatic drugs
P Lee, J Webb, J Anderson, et al.
British Journal of Medical Education
|
September 1, 1972
Rheumatology--the 'Cinderella' specialty--an examination of doctors' attitudes to training and carrers
B L Bennett, W W Buchanan, R M Harden
The Practitioner
|
August 1, 1974
Diagnostic problems in joint disease
W W Buchanan, R D Sturrock, S J Ahola
The European Journal of Neuroscience
|
March 30, 2021
Subjective stress and proactive and reactive cognitive control strategies
Robyn A Husa, Tony W Buchanan, Brenda A Kirchhoff
Schizophrenia Bulletin
|
February 14, 2006
Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia
David Potter, Ann Summerfelt, James Gold, et al.
Page
of 85
Search research articles
Search
Showing results (271-280 of 841) with videos related to
Sort By:
Page
of 85
Anxiety
|
January 1, 1996
What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?
A W Buchanan, K S Meng, I M Marks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1981
Pitfalls in technetium-99m HIDA biliary imaging: duodenal diverticulum simulating the gallbladder
J F Brown, J W Buchanan, H N Wagner
British Journal of Clinical Pharmacology
|
October 1, 1988
Comparison of the natural history of untreated acute gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs
M H Arnold, S J Preston, W W Buchanan
International Clinical Psychopharmacology
|
August 5, 1998
The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
C A Tamminga, R W Buchanan, J M Gold
Schizophrenia Bulletin Open
|
August 15, 2024
Time to Stop Using the Term Relapse in Schizophrenia Clinical Trials
William T Carpenter, Robert W Buchanan, Stephen R Marder
Annals of the Rheumatic Diseases
|
January 1, 1974
Proceedings: Technique for assessing the potential effectiveness of antirheumatic drugs
P Lee, J Webb, J Anderson, et al.
British Journal of Medical Education
|
September 1, 1972
Rheumatology--the 'Cinderella' specialty--an examination of doctors' attitudes to training and carrers
B L Bennett, W W Buchanan, R M Harden
The Practitioner
|
August 1, 1974
Diagnostic problems in joint disease
W W Buchanan, R D Sturrock, S J Ahola
The European Journal of Neuroscience
|
March 30, 2021
Subjective stress and proactive and reactive cognitive control strategies
Robyn A Husa, Tony W Buchanan, Brenda A Kirchhoff
Schizophrenia Bulletin
|
February 14, 2006
Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia
David Potter, Ann Summerfelt, James Gold, et al.
Page
of 85